Trial Profile
A phase I study of alofanib in patients with platinum resistant ovarian cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Alofanib (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; First in man
- 30 Jul 2015 New trial record